Celldex Therapeutics
CLDX
#4701
Rank
C$2.73 B
Marketcap
C$41.11
Share price
-0.51%
Change (1 day)
12.51%
Change (1 year)

Celldex Therapeutics (CLDX) - Total debt

Total debt on the balance sheet as of September 2025 : C$3.65 Million

According to Celldex Therapeutics's latest financial reports the company's total debt is C$3.65 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Celldex Therapeutics - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$5.47 M62.29%
2023-12-31C$3.37 M-38.39%
2022-12-31C$5.47 M41.16%
2021-12-31C$3.87 M-12.65%
2020-12-31C$4.43 M-7.07%
2019-12-31C$4.77 M
2018-12-31N/A-100%
2017-12-31C$8.25 M
2015-12-31C$6.12 M103.75%
2014-12-31C$3 M
2013-12-31N/A-100%
2012-12-31C$11.27 M-26.81%
2011-12-31C$15.4 M42.45%
2010-12-31C$10.81 M-25.74%
2009-12-31C$14.56 M5393.89%
2008-12-31C$0.26 M-94.86%
2007-12-31C$5.15 M-4.62%
2006-12-31C$5.4 M122.42%
2005-12-31C$2.43 M984.91%
2004-12-31C$0.22 M
2000-12-31C$0.41 M-49.34%
1999-12-31C$0.81 M-67%
1998-12-31C$2.46 M7.61%
1997-12-31C$2.28 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Seagen
SGEN
C$0.15 B 4,229.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$63.89 M 1,646.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.92 B 25,199.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$76.20 B 2,082,578.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$84.94 B 2,321,456.66%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$33.31 B 910,315.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA